Gene · 338557
Papers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding dietary fat: molecular sensing, brain integration, and the biology of flavor. | Can J Physiol Pharmacol | 2026 | 42826400 | PubTator, text mining | PubMed |
| Molecular mechanisms of lipid sensing in human cholecystokinin-secreting enteroendocrine cells. | Mol Metab | 2026 | 42805486 | PubTator, text mining | PubMed |
| Multi-population genome-wide association meta-analysis of acute and chronic pancreatitis. | medRxiv | 2026 | 42780122 | PubTator, text mining | PubMed |
| Antidepressant mechanism of sns in repairing synaptic damage via the GPR120/NLRP3 pathway-mediated inhibition of microglial M1 polarization. | Phytomedicine | 2026 | 42664588 | PubTator, text mining | PubMed |
Corrigendum to "Free-Fatty Acid Receptor-4 (FFA4/GPR120) differentially regulates migration, invasion, proliferation and tumor growth of papillary renal cell carcinoma cells" [Biochem. Pharmacol. 213 (2023) 115590]. | Biochem Pharmacol | 2026 | 42607359 | PubTator, text mining | PubMed |
| GPR120/free fatty acid receptor 4 (FFAR-4) agonists, antagonists, allosteric modulators: Computational drug design and discovery review. | Eur J Med Chem | 2026 | 42372394 | PubTator, text mining | PubMed |
| Spent Coffee Ground Extracts: A Sustainable Source of Antioxidant and Immunomodulatory Bioactives for Managing Lifestyle-Related Chronic Diseases. | Int J Mol Sci | 2026 | 42278504 | PubTator, text mining | PubMed |
| Modeling stimulus-induced stress responses in microglia-like cells using a commercial iPSC-dCas9-KRAB line. | Stem Cell Res | 2026 | 42214129 | PubTator, text mining | PubMed |
| Nmur1 and Cckar fail to support functional genetic access in adult dopamine neurons and challenge GPCR atlas assignments. | bioRxiv | 2026 | 42182265 | PubTator, text mining | PubMed |
| Impact of critical-site mutations in the free fatty acid receptor 4 on the allosteric kinetics of endogenous fatty acid-receptor interactions. | Anal Chim Acta | 2026 | 42108048 | PubTator, text mining | PubMed |
| The roles of free-fatty acid receptors in the pathophysiology of renal disorders. | J Pharmacol Exp Ther | 2026 | 42096898 | PubTator, text mining | PubMed |
| Short-, medium-, versus long-chain fatty acids: mechanisms of immunomodulation and disease pathogenesis. | Cell Mol Immunol | 2026 | 42056219 | PubTator, text mining | PubMed |
| Fueling the fire or dousing the flame? The unclear role of the free-fatty acid receptor-4 (FFA4/GPR120) in colorectal cancer. | Biochem Pharmacol | 2026 | 41956426 | PubTator, text mining | PubMed |
| The Multifaceted Roles of GPR120 in Central Nervous System Disorders: Mechanistic Insights and Therapeutic Implications. | Mol Neurobiol | 2026 | 41915334 | PubTator, text mining | PubMed |
| Fatty Acid-Sensing G Protein-Coupled Receptors in Skeletal Metabolism. | J Bone Metab | 2026 | 41850316 | PubTator, text mining | PubMed |
| Maternal 12-HETE is associated with childhood asthma and the responses to prenatal omega-3 supplementation. | Cell Rep Med | 2026 | 41850235 | PubTator, text mining | PubMed |
| Endothelial Ffar4 protects against diabetic kidney disease by potentiating endogenous retinoic acid metabolism. | Cell Mol Biol Lett | 2026 | 41832416 | PubTator, text mining | PubMed |
| METTL3-m6A Promotes FFAR4 Levels in Patients with Endocrine Dysfunctional Osteoporosis Syndrome. | Comb Chem High Throughput Screen | 2026 | 41830139 | PubTator, text mining | PubMed |
| Maternal docosahexaenoic acid and eicosapentaenoic acid supplementation: effects and mechanisms on lipid metabolism in the offspring. | Front Nutr | 2026 | 41798834 | PubTator, text mining | PubMed |
| FFAR4 negatively regulates colorectal cancer growth via blocking oxidative phosphorylation. | J Transl Med | 2026 | 41787450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338557/papers